Glossary

Peptide Therapy Protocols

Structured clinical programs that use compounded peptide compounds to support specific therapeutic goals such as recovery, body composition, or hormonal balance.

Peptide therapy protocols define how peptide compounds are prescribed, dosed, and monitored within a clinical program. A protocol specifies which peptide or peptide combination is appropriate for a given patient profile, starting doses, titration schedules, injection instructions, and criteria for adjusting or discontinuing treatment. Protocols are the clinical backbone that makes a peptide program defensible and consistent across providers.

For operators, having defined protocols is both a compliance requirement and an operational advantage. Providers following a standardized protocol produce more consistent outcomes and are easier to train and oversee. Protocols also enable asynchronous or AI-assisted intake, since structured intake data can be evaluated against protocol criteria without requiring a live provider encounter for every patient.

Peptide programs can cover a range of therapeutic areas - BPC-157 for recovery, CJC-1295 and ipamorelin for growth hormone support, PT-141 for sexual health, and others. Karpa's platform supports configurable protocols across these categories, with provider workflows and pharmacy integrations built around each program type.

Related Solution

Launch your Peptide Therapy Protocols program with Karpa

See How It Works

Related Terms

Pharmacy Integration Telehealth Prescribing AI Clinical Triage

Frequently Asked Questions

Are peptides FDA-approved? expand_more
Most peptides used in clinical programs are not FDA-approved as finished drug products. They are compounded by licensed pharmacies and prescribed for specific patients. The legality of compounding specific peptides depends on the current FDA bulk substance list. Operators should confirm eligibility with their pharmacy and legal counsel.
How do operators configure a peptide protocol on Karpa? expand_more
Karpa's platform includes a protocol builder where operators define eligible patient criteria, default dosing, titration schedules, and follow-up intervals. Providers receive the protocol as structured clinical guidance during case review.
What are the most common peptide programs operators run? expand_more
Common programs include GH secretagogue protocols using CJC-1295 and ipamorelin, BPC-157 for recovery and injury support, and PT-141 for sexual health. GLP-1 compounds like semaglutide and tirzepatide are also peptides, though they are typically categorized separately due to their FDA regulatory history.

Ready to launch your clinic?

Karpa provides everything you need to go live in 2 weeks or less.

Book a Free Demo